Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Startups & Unicorns companies in Calcium channel blocker
by Highest Patent Value in the United States in 2021

The Calcium channel blocker top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Calcium channel blocker Startups & Unicorns in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Calcium channel blockers (CCB), calcium channel antagonists or calcium antagonists are a group of medications that disrupt the movement of calcium (Ca²⁺) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.
#
Company Name
Region
Tech Topics
Total
1
Nocion Therapeutics, Inc.
Intracellular sodium,Health care,Inflammation,
...[+1]
Avg patent value: 77,111
2
Seattle Gummy Co.
Snack foods,Nutrition,Organic matter,
...[+2]
Avg patent value: 17,000
3
SyntheX, Inc.
Biology,Medicine,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 0
4
Nevakar LLC
Medical equipment,Center of excellence,Molecule,
...[+2]
Avg patent value: 0
5
ResQ Pharmaceuticals, Inc.
Herb,Botanical drug
Avg patent value: 0
Page generation time: Jun 29 2025